Aaron Rosenberg, Chief Financial Officer at BeOne Medicines Ltd. (ONC), sold 2,380 shares at $290.47 ($691K) on 2025-08-01, disclosed to the SEC on 2025-08-05.
Open-market sale of $691k ONC by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $290.47 | 1,190 | $346K | 50.0% |
| 2 | $290.47 | 1,190 | $346K | 50.0% |
| Total | $290.47 avg | 2,380 | $691K | 100% |
| Filing → |